These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 35000532)

  • 21. Dysphagia-optimised intensity-modulated radiotherapy versus standard intensity-modulated radiotherapy in patients with head and neck cancer (DARS): a phase 3, multicentre, randomised, controlled trial.
    Nutting C; Finneran L; Roe J; Sydenham MA; Beasley M; Bhide S; Boon C; Cook A; De Winton E; Emson M; Foran B; Frogley R; Petkar I; Pettit L; Rooney K; Roques T; Srinivasan D; Tyler J; Hall E;
    Lancet Oncol; 2023 Aug; 24(8):868-880. PubMed ID: 37423227
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial.
    Nutting CM; Morden JP; Harrington KJ; Urbano TG; Bhide SA; Clark C; Miles EA; Miah AB; Newbold K; Tanay M; Adab F; Jefferies SJ; Scrase C; Yap BK; A'Hern RP; Sydenham MA; Emson M; Hall E;
    Lancet Oncol; 2011 Feb; 12(2):127-36. PubMed ID: 21236730
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of Radiation on Dysphagia-Related Structures: A Dosimetric and Clinical Comparative Analysis of Three-Dimensional Conformal Radiotherapy (3D-CRT) and Intensity-Modulated Radiation Therapy (IMRT) Techniques in Patients With Head and Neck Cancer.
    Manam S; Teja R; Pb AR; Azharuddin SK
    Cureus; 2024 Apr; 16(4):e58276. PubMed ID: 38752101
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Study to Assess the Dosimetric Impact of the Anatomical Changes Occurring in the Parotid Glands and Tumour Volume during Intensity Modulated Radiotherapy using Simultaneous Integrated Boost (IMRT-SIB) in Head and Neck Squamous Cell Cancers.
    Ghosh A; Gupta S; Johny D; Vidyadhar Bhosale V; Pal Singh Negi M
    Cancer Med; 2021 Aug; 10(15):5175-5190. PubMed ID: 34159749
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patterns of local-regional recurrence following parotid-sparing conformal and segmental intensity-modulated radiotherapy for head and neck cancer.
    Dawson LA; Anzai Y; Marsh L; Martel MK; Paulino A; Ship JA; Eisbruch A
    Int J Radiat Oncol Biol Phys; 2000 Mar; 46(5):1117-26. PubMed ID: 10725621
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Volume changes during head-and-neck radiotherapy and its impact on the parotid dose - A single-institution observational study.
    Ilangovan B; Venkatraman M; Balasundaram S
    J Cancer Res Ther; 2020; 16(3):575-580. PubMed ID: 32719270
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pattern of dysphagia after swallowing-sparing intensity-modulated radiotherapy (IMRT) of head and neck cancers: results of a mono-institutional prospective study.
    Ursino S; Cocuzza P; Seccia V; Delishaj D; Cristaudo A; Pasqualetti F; Giusti P; Santopadre S; Morganti R; Fiorica F; Paiar F; Fattori B
    Strahlenther Onkol; 2018 Dec; 194(12):1114-1123. PubMed ID: 29987341
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patient-Reported Outcomes After Swallowing (SWOARs)-Sparing IMRT in Head and Neck Cancers: Primary Results from a Prospective Study Endorsed by the Head and Neck Study Group (HNSG) of the Italian Association of Radiotherapy and Clinical Oncology (AIRO).
    Ursino S; Calistri E; De Felice F; Bonomo P; Desideri I; Franco P; Arcadipane F; Colosimo C; Mazzola R; Maddalo M; Gonnelli A; Malfatti G; Morganti R; Musio D; Paiar F
    Dysphagia; 2023 Feb; 38(1):159-170. PubMed ID: 35587295
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dosimetric comparison of volumetric-arc therapy versus sliding window intensity-modulated radiotherapy in postoperative treatment for primary soft tissue sarcoma of the thigh.
    Ortiz González I; Morera Cano D; Roncero Sánchez R; Mateos Salvador P; Valencia Blanco L; Vidal Borrás M; Aymar Salís N; Gadea Quinteiro J; Jiménez Jiménez E; Gelabert JF; Pardo Masferrer J
    Asia Pac J Clin Oncol; 2019 Dec; 15(6):371-376. PubMed ID: 31321885
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A dosimetric comparison of volumetric modulated arc therapy (VMAT) and non-coplanar intensity modulated radiotherapy (IMRT) for nasal cavity and paranasal sinus cancer.
    Jeong Y; Lee SW; Kwak J; Cho I; Yoon SM; Kim JH; Park JH; Choi EK; Song SY; Kim YS; Kim SS; Joo JH; Ahn SD
    Radiat Oncol; 2014 Aug; 9():193. PubMed ID: 25175383
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of salivary gland dosimetry on post-IMRT recovery of saliva output and xerostomia grade for head-and-neck cancer patients treated with or without contralateral submandibular gland sparing: a longitudinal study.
    Wang ZH; Yan C; Zhang ZY; Zhang CP; Hu HS; Tu WY; Kirwan J; Mendenhall WM
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1479-87. PubMed ID: 20934262
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A study on the impact of patient-related parameters in the ability to spare parotid glands by intensity-modulated radiotherapy for head and neck squamous cell carcinomas.
    Bandlamudi BP; Sharan K; Yathiraj PH; Singh A; Reddy A; Fernandes DJ; Srinivasa VM
    J Cancer Res Ther; 2018; 14(6):1220-1224. PubMed ID: 30488833
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Can dose reduction to one parotid gland prevent xerostomia?--A feasibility study for locally advanced head and neck cancer patients treated with intensity-modulated radiotherapy.
    Anand AK; Jain J; Negi PS; Chaudhoory AR; Sinha SN; Choudhury PS; Kumar R; Munjal RK
    Clin Oncol (R Coll Radiol); 2006 Aug; 18(6):497-504. PubMed ID: 16909975
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incorporating single-side sparing in models for predicting parotid dose sparing in head and neck IMRT.
    Yuan L; Wu QJ; Yin FF; Jiang Y; Yoo D; Ge Y
    Med Phys; 2014 Feb; 41(2):021728. PubMed ID: 24506619
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative Study of Dysphagia-optimized Intensity Modulated Radiotherapy (Do-IMRT) and Standard Intensity Modulated Radiotherapy (S-IMRT) and Its Clinical Correlation in Head and Neck Cancer Patients.
    Batham S; Gupta S; Ghosh A; Gupta IJ; Johny D; Srivastava S; Singh N; Bhatt M; Gupta R; Bhosale VV; Negi M
    Asian Pac J Cancer Prev; 2023 Nov; 24(11):3697-3704. PubMed ID: 38019227
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Simple tool for prediction of parotid gland sparing in intensity-modulated radiation therapy.
    Gensheimer MF; Hummel-Kramer SM; Cain D; Quang TS
    Med Dosim; 2015; 40(3):232-4. PubMed ID: 25704638
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dysphagia and aspiration after chemoradiotherapy for head-and-neck cancer: which anatomic structures are affected and can they be spared by IMRT?
    Eisbruch A; Schwartz M; Rasch C; Vineberg K; Damen E; Van As CJ; Marsh R; Pameijer FA; Balm AJ
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1425-39. PubMed ID: 15590174
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recurrences near base of skull after IMRT for head-and-neck cancer: implications for target delineation in high neck and for parotid gland sparing.
    Eisbruch A; Marsh LH; Dawson LA; Bradford CR; Teknos TN; Chepeha DB; Worden FP; Urba S; Lin A; Schipper MJ; Wolf GT
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):28-42. PubMed ID: 15093896
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Randomized controlled study comparing simultaneous modulated accelerated radiotherapy versus simultaneous integrated boost intensity modulated radiotherapy in the treatment of locally advanced head and neck cancer.
    Tandon S; Gairola M; Ahlawat P; Rawat S; Aggarwal A; Sharma K; Tiwari S; Karimi AM; Muttagi V; Sachdeva N; Bhushan M
    J Egypt Natl Canc Inst; 2018 Sep; 30(3):107-115. PubMed ID: 29960876
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intensity modulated radiotherapy improves target coverage and parotid gland sparing when delivering total mucosal irradiation in patients with squamous cell carcinoma of head and neck of unknown primary site.
    Bhide S; Clark C; Harrington K; Nutting CM
    Med Dosim; 2007; 32(3):188-95. PubMed ID: 17707198
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.